![]() ![]() Participants described how the use of restrictive take-home dose policies negatively impacted their ability to meet day-to-day responsibilities and also cited the need for daily attendance as a reason for quitting or avoiding OAT. Nearly all of the patients with past or present MMT use were highly critical of the limited access to take-home doses and consequent need for daily or near daily clinic attendance. Interviews explored: reasons for engaging with, or not engaging with MMT how MMT is conceptualized by patients and treatment providers (e.g., as harm reduction or route to abstinence and/or recovery) experiences with MMT perception of barriers to MMT (e.g., organizational/regulatory, social) and how MMT might be improved to support peoples’ substance use treatment needs and goals. ![]() This article is based on semi-structured, qualitative interviews with a variety of stakeholders in MMT. In response, this article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general. Yet, MMT’s use of restrictive take-home dose policies that force most patients to attend their clinic on a daily, or near-daily, basis may be unpopular with many patients and lead to low rates of treatment uptake and retention. Methadone Maintenance Treatment (MMT) is widely recognized as one of the most effective ways of reducing risk of overdose, arrest, and transmission of blood-borne viruses like HIV and HCV among people that use opioids. ![]()
0 Comments
Leave a Reply. |